Abstract:Targeting mitochondria has always been a challenging goal for therapeutic nanoparticle agents due to their heterotypic features and size, which usually lead to a lysosome/endosome endocytosis pathway. To overcome this limitation, in this work, a portfolio targeting strategy combining a small targeting molecule with a biomembrane was developed. Modification of small targeting molecule H2N-TPP on gold nanoparticles (GNPs) could not only facilitate the mitochondrial targeting but could also induce gold nanoparticle assembly. Therefore, the GNPs were endowed with good absorption and photothermal conversion abilities in the near-infrared (NIR) region. Meanwhile, a biomimetic strategy was adopted by wrapping the gold nanoparticle assembly (GNA) with cancer cell membranes (CCMs), which helped the GNA enter the prostatic cancer cell via a homotypic membrane-fusion process to avoid being trapped in endosomes/lysosomes. Thereafter, the GNA remaining in the cytoplasm could reach mitochondria more efficiently via guidance from H2N-TPP molecules. This "biomembrane–small molecule" combination targeting process was evidenced by fluorescence microscopy, and the highly efficient photothermal ablation of prostatic tumors in vivo was demonstrated. This portfolio targeting strategy could be extended to various nanodrugs/agents to realize an accurate subcellular targeting efficiency for cancer treatments or cell detections.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.bioconjchem.0c00518?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.bioconjchem.0c00518</a>.1H NMR spectrum of H2N-TPP. TEM images of GNPs. Photothermal properties of pure water. Confocal microscopy images of the cellular uptake of CCM–FITC–TPP–GNA/FITC–TPP–GNA. ICP analysis of the Au content in PC-3 cells after uptake of CCM–FITC–TPP–GNA/FITC–TPP–GNA. Cell toxicity of TPP–GNA with/without laser irradiation. UV–vis absorbance spectra of DiI dye and DiI–CCM–TPP–GNA. UV–vis absorbance spectra of DiI dye, DiI-labeled CCM–TPP–GNA, FITC and FITC-labeled CCM–TPP–GNA. Infrared thermography and temperature change at the tumor area irradiated by NIR laser (808 nm, 2 W/cm2) for different time after injection of PBS and CCM–TPP–GNA (<a class="ext-link" href="/doi/suppl/10.1021/acs.bioconjchem.0c00518/suppl_file/bc0c00518_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Hemoglobin Assisted Synthesis of Au NCs@MBA-TPP Nanoadapters for Mitochondria Targeted Multimodal Combined Therapy

Mitochondrial-targeted multifunctional mesoporous Au@Pt nanoparticles for dual-mode photodynamic and photothermal therapy of cancers.

Design of the Tumor Microenvironment-Multiresponsive Nanoplatform for Dual-Targeting and Photothermal Imaging Guided Photothermal/photodynamic/chemodynamic Cancer Therapies with Hypoxia Improvement and GSH Depletion

Highly Efficient GSH-Responsive “Off–On” NIR-II Fluorescent Fenton Nanocatalyst for Multimodal Imaging-Guided Photothermal/Chemodynamic Synergistic Cancer Therapy

Endogenous oxygen generating multifunctional theranostic nanoplatform for enhanced photodynamic-photothermal therapy and multimodal imaging

An Intelligent Triple Assisted Gold Cluster‐Based Nanosystem for Enhanced Tumor Photodynamic Therapy

Multifunctional Nanozymes by Amplifying Intracellular Oxidative Stress for Enhanced Photothermal–Photodynamic Therapy

A Tumor-Mitochondria Dual Targeted Aza-Bodipy-based Nanotheranostic Agent for Multimodal Imaging-Guided Phototherapy

Engineered cells-assisted photoactive nanoparticles delivery for image-guided synergistic photodynamic/photothermal therapy of cancer.

TME-targeting nano-theranostic agent for NIR fluorescence diagnosis and O2-economized PDT-based multimodal synergistic therapy

3-Bromopyruvate-loaded Ti3C2 MXene/Cu2O Nanosheets for Photoacoustic Imaging-Guided and Hypoxia-Relieving Enhanced Photothermal/Chemodynamic Therapy.

Multifunctional Hyaluronic Acid Ligand-Assisted Construction of CD44-and Mitochondria-Targeted Self-Assembled Upconversion Nanoparticles for Enhanced Photodynamic Therapy

Multifunctional MnO2/Ag3SbS3 Nanotheranostic Agent for Single-Laser-Triggered Tumor Synergistic Therapy in the NIR-II Biowindow

Dual-responsive and NIR-driven Free Radical Nanoamplifier with Glutathione Depletion for Enhanced Tumor-Specific Photothermal/thermodynamic/chemodynamic Synergistic Therapy.

Biomimetic mesoporous polydopamine nanoparticles for MRI-guided photothermal-enhanced synergistic cascade chemodynamic cancer therapy

AuPt-Loaded Cu-Doped Polydopamine Nanocomposites with Multienzyme-Mimic Activities for Dual-Modal Imaging-Guided and Cuproptosis-Enhanced Photothermal/Nanocatalytic Therapy.

Mitochondria-Targeting MoS 2 -Based Nanoagents for Enhanced NIR-II Photothermal-Chemodynamic Synergistic Oncotherapy

Portfolio Targeting Strategy To Realize the Assembly and Membrane Fusion-Mediated Delivery of Gold Nanoparticles to Mitochondria for Enhanced NIR Photothermal Therapies

In-situ bio-assembled specific Au NCs-Aptamer-Pyro conjugates nanoprobe for tumor imaging and mitochondria-targeted photodynamic therapy

A Ph-Activatable Nanoparticle for Dual-Stage Precisely Mitochondria-Targeted Photodynamic Anticancer Therapy.

In-situ Fabrication of Novel Au Nanoclusters-Cu2+@sodium Alginate/hyaluronic Acid Nanohybrid Gels for Cuproptosis Enhanced Photothermal/photodynamic/chemodynamic Therapy Via Tumor Microenvironment Regulation